KEITH LUI: Open Payments
NPI 1235519612 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 19 payments from 7 companies in 2025. Trend: 2023 $61 · 2024 $150 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $159 |
| Janssen Pharmaceuticals, Inc | 4 | $119 |
| Axsome Therapeutics, Inc. | 3 | $79 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Bausch Health US, LLC | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: VRAYLAR, SPRAVATO, Auvelity, REXULTI, INGREZZA, APLENZIN, CAPLYTA.
Industry payments across CA — which companies pay providers there.
